Literature DB >> 22177559

Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.

Nadia R Roan1, Janis A Müller, Haichuan Liu, Simon Chu, Franziska Arnold, Christina M Stürzel, Paul Walther, Ming Dong, H Ewa Witkowska, Frank Kirchhoff, Jan Münch, Warner C Greene.   

Abstract

Semen serves as a vehicle for HIV and promotes sexual transmission of the virus, which accounts for the majority of new HIV cases. The major component of semen is the coagulum, a viscous structure composed predominantly of spermatozoa and semenogelin proteins. Due to the activity of the semen protease PSA, the coagulum is liquefied and semenogelins are cleaved into smaller fragments. Here, we report that a subset of these semenogelin fragments form amyloid fibrils that greatly enhance HIV infection. Like SEVI, another amyloid fibril previously identified in semen, the semenogelin fibrils exhibit a cationic surface and enhance HIV virion attachment and entry. Whereas semen samples from healthy individuals greatly enhance HIV infection, semenogelin-deficient semen samples from patients with ejaculatory duct obstruction are completely deficient in enhancing activity. Semen thus harbors distinct amyloidogenic peptides derived from different precursor proteins that commonly enhance HIV infection and likely contribute to HIV transmission.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177559      PMCID: PMC3257029          DOI: 10.1016/j.chom.2011.10.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  38 in total

1.  Variation in virological parameters and antibody responses in macaques after atraumatic vaginal exposure to a pathogenic primary isolate of SIVmac251.

Authors:  O Neildez; R Le Grand; A Chéret; P Caufour; B Vaslin; F Matheux; F Théodoro; P Roques; D Dormont
Journal:  Res Virol       Date:  1998 Jan-Feb

2.  Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV.

Authors:  Emmanuel Balandya; Siddharth Sheth; Katherine Sanders; Wendy Wieland-Alter; Timothy Lahey
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

3.  The abundant 19-kilodalton protein associated with human sperm nuclei that is related to seminal plasma alpha-inhibins.

Authors:  A O Zalensky; P Yau; J W Breneman; E M Bradbury
Journal:  Mol Reprod Dev       Date:  1993-10       Impact factor: 2.609

4.  Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process.

Authors:  E de Lamirande; K Yoshida; T M Yoshiike; T Iwamoto; C Gagnon
Journal:  J Androl       Date:  2001 Jul-Aug

5.  Clomiphene citrate administration to normogonadotropic subfertile men: blood hormone changes and activation of acid phosphatase in seminal fluid.

Authors:  L Rönnberg; P Vihko; E Sajanti; R Vihko
Journal:  Int J Androl       Date:  1981-06

6.  Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).

Authors:  Nadia R Roan; Stefanie Sowinski; Jan Münch; Frank Kirchhoff; Warner C Greene
Journal:  J Biol Chem       Date:  2009-11-06       Impact factor: 5.157

7.  The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.

Authors:  Nadia R Roan; Jan Münch; Nathalie Arhel; Walther Mothes; Jason Neidleman; Akiko Kobayashi; Karen Smith-McCune; Frank Kirchhoff; Warner C Greene
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

8.  The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelins.

Authors:  Anneli M L Edström; Johan Malm; Birgitta Frohm; Julie A Martellini; Aleksander Giwercman; Matthias Mörgelin; Alexander M Cole; Ole E Sørensen
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Semen-derived amyloid fibrils drastically enhance HIV infection.

Authors:  Jan Münch; Elke Rücker; Ludger Ständker; Knut Adermann; Christine Goffinet; Michael Schindler; Steffen Wildum; Raghavan Chinnadurai; Devi Rajan; Anke Specht; Guillermo Giménez-Gallego; Pedro Cuevas Sánchez; Douglas M Fowler; Atanas Koulov; Jeffery W Kelly; Walther Mothes; Jean-Charles Grivel; Leonid Margolis; Oliver T Keppler; Wolf-Georg Forssmann; Frank Kirchhoff
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

10.  Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.

Authors:  Joanna S Olsen; Caitlin Brown; Christina C Capule; Mark Rubinshtein; Todd M Doran; Rajesh K Srivastava; Changyong Feng; Bradley L Nilsson; Jerry Yang; Stephen Dewhurst
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

View more
  83 in total

1.  Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.

Authors:  Onofrio Zirafi; Kyeong-Ae Kim; Nadia R Roan; Silvia F Kluge; Janis A Müller; Shibo Jiang; Benjamin Mayer; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Sci Transl Med       Date:  2014-11-12       Impact factor: 17.956

2.  Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.

Authors:  Franziska Arnold; Jacqueline Schnell; Onofrio Zirafi; Christina Stürzel; Christoph Meier; Tanja Weil; Ludger Ständker; Wolf-Georg Forssmann; Nadia R Roan; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 3.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

4.  Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.

Authors:  Qiyi Tang; Nadia R Roan; Yasuhiro Yamamura
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  [Lactic acid inhibits the formation of semen-derived amyloid fibrils].

Authors:  Jin-Qing Li; Ya-Li Song; Tian-Rong Xun; Sui-Yi Tan; Shu-Wen Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

6.  ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.

Authors:  Tianrong Xun; Wenjuan Li; Jinquan Chen; Fei Yu; Wei Xu; Qian Wang; Ruizhe Yu; Xiaojuan Li; Xuefeng Zhou; Lu Lu; Shibo Jiang; Lin Li; Suiyi Tan; Shuwen Liu
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

7.  Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity.

Authors:  Jeremy Di Domizio; Stephanie Dorta-Estremera; Mihai Gagea; Dipyaman Ganguly; Stephan Meller; Ping Li; Bihong Zhao; Filemon K Tan; Liqi Bi; Michel Gilliet; Wei Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

8.  A molecular tweezer antagonizes seminal amyloids and HIV infection.

Authors:  Edina Lump; Laura M Castellano; Christoph Meier; Janine Seeliger; Nelli Erwin; Benjamin Sperlich; Christina M Stürzel; Shariq Usmani; Rebecca M Hammond; Jens von Einem; Gisa Gerold; Florian Kreppel; Kenny Bravo-Rodriguez; Thomas Pietschmann; Veronica M Holmes; David Palesch; Onofrio Zirafi; Drew Weissman; Andrea Sowislok; Burkhard Wettig; Christian Heid; Frank Kirchhoff; Tanja Weil; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Elsa Sanchez-Garcia; Roland Winter; James Shorter; Jan Münch
Journal:  Elife       Date:  2015-08-18       Impact factor: 8.140

9.  Sexual violence and HIV transmission: summary proceedings of a scientific research planning meeting.

Authors:  Jennifer F Klot; Judith D Auerbach; Miranda R Berry
Journal:  Am J Reprod Immunol       Date:  2012-11-12       Impact factor: 3.886

10.  Repurposing Hsp104 to Antagonize Seminal Amyloid and Counter HIV Infection.

Authors:  Laura M Castellano; Stephen M Bart; Veronica M Holmes; Drew Weissman; James Shorter
Journal:  Chem Biol       Date:  2015-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.